Navigation Links
Quality of Life Key Measure in Breast Cancer Clinical Trials
Date:1/7/2011

FRIDAY, Jan. 7 (HealthDay News) -- Making decisions about breast cancer treatment based on measures of a patient's general well-being, stress level and ability to enjoy normal life activities is most effective in clinical trials in which quality of life is the primary outcome, a new Canadian study shows.

Researchers from Laval University in Quebec, Canada reviewed 190 clinical trials of breast cancer treatments and found that quality of life (QOL) measures were most useful for clinical decisions in trials that used non-biomedical interventions such as group therapy.

QOL measures should also be included in clinical trials of metastatic breast cancer treatments when a minimal survival difference is expected or when treatments have substantial differences in toxicity, the researchers said.

In a news release, the researchers said that when quality of life is not the primary endpoint of a clinical trial, "QOL results should ideally appear in a companion article published at the same time as the traditional medical outcomes article so that a full view of the risks and benefits of the intervention can be presented at the same time to clinicians."

The researchers noted that both the World Health Organization and the U.S. Food and Drug Administration stress the importance of patients' quality of life, but that clinical trials sometimes don't include that measure due to the cost of collecting the data.

In an accompanying editorial quoted in the journal news release, Dr. Patricia Ganz of the University of California at Los Angeles commented that the increase in studies considering quality of life "reflects the increased acceptance of the patients' voice in assessing the outcome of [breast cancer treatment] trials."

The study appears online in the Jan. 7 issue of the Journal of the National Cancer Institute.

More information

Breastcancer.org outlines day-to-day matters that can affect breast cancer patients' quality of life.

-- Robert Preidt

SOURCE: Journal of the National Cancer Institute, news release, Jan. 7, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researchers measure quality of care in oral anticoagulation
2. Better Methods Needed to Measure Hospital Quality: Experts
3. Mortality rates are an unreliable metric for assessing hospital quality, study finds
4. James W. Varnum National Quality Award presented to Project SEARCH
5. Active surveillance for low-risk prostate cancer may offer better quality-of-life
6. Professor Zvi Ram presents phase III recurrent glioblastoma survival and quality of life data from the first pivotal study of the NovoTTF-100A at 15th Annual Society for Neuro-Oncology Scientific Meeting
7. Lung cancer patients are the centerpiece for Northwestern medicine quality of care study
8. Poor sleep quality increases inflammation, community study finds
9. Penn study: Hospital CPR quality is worse at night
10. Higher medication spending doesnt indicate better prescribing quality
11. National Quality Forum picks AMIA for national priorities partnership
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Quality of Life Key Measure in Breast Cancer Clinical Trials
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... Wine Tasting Event in New York City, with long-time partners The Paul Foundation, ...
(Date:12/4/2016)... ... December 04, 2016 , ... "Pro3rd Displace is ... styles with unique displacement design elements," said Christina Austin - CEO of Pixel ... from a variety of design styles that include both left aligned and right ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... will speak at the American Conference Institute’s 21st Drug & Medical Device Litigation ... Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Advanced Inc., a ... has appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, ... Inc. , Jason brings extensive financial and operational leadership experience to Advanced Inc. ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... With ... struggling through rehabilitation of an injury, patients must find the one that works for ... his pain, he created a machine that worked and decided to share it with ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016 The U.S. Food ... Jardiance (empagliflozin) to reduce the risk of cardiovascular death ... cardiovascular disease. "Cardiovascular disease is a ... diabetes mellitus," said Jean-Marc Guettier , M.D., C.M., ... in FDA,s Center for Drug Evaluation and Research. "Availability ...
(Date:12/2/2016)... 2, 2016 Persistence Market Research ... its upcoming report titled, "Global Market Study on Cardiac Pacemaker: ... of -1.4% between 2016 and 2024". The global cardiac pacemaker ... and this is likely to decline to US$ 3923.8 ... cardiac pacemaker market is anticipated to exhibit a declining ...
(Date:12/2/2016)... NEW YORK , December 2, 2016 ... Market Research titled "Global Market Study on Automated Endoscope Reprocessors: ... Register a CAGR of 8.6% Between 2016 and 2024 " the ... 2015 and is expected to expand at a CAGR of ... market valuation of US$ 1,367.6 Mn by 2024. ...
Breaking Medicine Technology: